• Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer. 

      Abujamous, Lama; Soltani, Abderrezzaq; Al-Thawadi, Hamda; Agouni, Abdelali ( Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina , 2023 , Article Review)
      Advanced ovarian cancer is a malignancy that spreads beyond the ovaries to the pelvis, abdomen, lungs, or lymph nodes. Effective treatment options are available to improve survival rates in patients with advanced ovarian ...
    • Carbon nanotubes drug delivery system for cancer treatment 

      Banu, Abdallah; Elhissi, Abdelbary M.A.; Ahmed, Waqar; Najlah, Mohammad ( Academic Press , 2020 , Book chapter)
      There has been a predominant interest in using nanotechnology for drug delivery applications, especially for cite-specific targeting. Recently, interest in the potential of carbon nanotubes (CNT) to deliver bio-molecules ...
    • Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes 

      Jung, Sungwook; Ben Nasr, Moufida; Bahmani, Baharak; Usuelli, Vera; Zhao, Jing; ... more authors ( John Wiley and Sons Inc , 2023 , Article)
      Immune therapeutics holds great promise in the treatment of type 1 diabetes (T1D). Nonetheless, their progress is hampered by limited efficacy, equipoise, or issues of safety. To address this, a novel and specific nanodelivery ...
    • Nanotechnology in medicine – our experiences 

      Geskovski, Nikola; Mraiche, Fatima; Yalcin, Huseyin C.; Gorachinov, Filip; Moustafa, Diala A.; ... more authors ( Macedonian Pharmaceutical Association , 2022 , Article)
      The success of design criteria for long-circulating drug delivery systems to support membrane receptor-ligand interaction and internalization has been limited and there is a need to develop smarter approaches for efficient ...
    • Quality by Design Approach in Liposomal Formulations: Robust Product Development 

      Alshaer, Walhan; Nsairat, Hamdi; Lafi, Zainab; Hourani, Omar M.; Al-Kadash, Abdulfattah; ... more authors ( Multidisciplinary Digital Publishing Institute (MDPI) , 2022 , Article)
      Nanomedicine is an emerging field with continuous growth and differentiation. Liposomal formulations are a major platform in nanomedicine, with more than fifteen FDA-approved liposomal products in the market. However, as ...
    • Rational development of nanomedicines for molecular targeting in periodontal disease 

      Geskovski N.; Sazdovska S.D.; Gjosheva S.; Petkovska R.; Popovska M.; ... more authors ( Elsevier Ltd , 2018 , Article Review)
      Recent advances in understanding the etiology and pathogenesis of periodontal disease and polymicrobial synergy in the dysbiotic oral microbial community endorsed novel therapeutic targets and assured further improvement ...
    • Reduced Cardiotoxicity of Ponatinib-Loaded PLGA-PEG-PLGA Nanoparticles in Zebrafish Xenograft Model. 

      Al-Thani, Hissa F; Shurbaji, Samar; Zakaria, Zain Zaki; Hasan, Maram H; Goracinova, Katerina; ... more authors ( MDPI , 2022 , Article)
      Tyrosine kinase inhibitors (TKIs) are the new generation of anti-cancer drugs with high potential against cancer cells' proliferation and growth. However, TKIs are associated with severe cardiotoxicity, limiting their ...